<DOC>
	<DOC>NCT00384280</DOC>
	<brief_summary>An open label, 2-period, sequential study to determine the impact of multiple doses of rifampin on single-dose pharmacokinetics of HCV-796</brief_summary>
	<brief_title>Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12lead electrocardiogram (ECG).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>